{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-024881","form_type":"8-K","ticker":"BFRI","cik":"0001858685","company_name":"Biofrontera Inc.","filed_at":"2024-06-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.934771+00:00","generated_at":"2026-06-01T02:35:37.510636+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Biofrontera launches FDA-approved RhodoLED XL lamp for PDT of actinic keratoses","bullets":["RhodoLED XL is FDA-approved for use with Ameluz (aminolevulinic acid) for mild-to-moderate actinic keratoses on face and scalp.","Commercial distribution launched June 10, 2024; first three machines shipped within one week.","Larger illumination area: five panels vs one on prior lamp; includes positioning sensors for optimal energy delivery.","First customer Cleaver Dermatology (MO and GA) installed the XL lamp; response from dermatology organizations is positive."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-024881","json":"https://secwatch.observer/filing/0001493152-24-024881.json","markdown":"https://secwatch.observer/filing/0001493152-24-024881.md","text":"https://secwatch.observer/filing/0001493152-24-024881.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1858685/000149315224024881/0001493152-24-024881-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1858685/000149315224024881/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T02:35:37.510636+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}